D'Souza Warren D, Rosen Isaac I
Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland 21201, USA.
Med Phys. 2003 Aug;30(8):2065-71. doi: 10.1118/1.1591991.
Treatment planning involves selecting delivery parameters that distribute the dose to nontumor tissue in such a way as to minimize the risk of complications. This work studied the relationship between nontumor integral dose (NTID), the fractional energy deposited in nontumor tissue, and a variety of delivery parameters for three clinical cases: nasopharynx, pancreas, and prostate. Integral dose for an organ of uniform density is simply the product of the organ density, volume, and mean dose. For each case, conventional plans were generated with 2, 4, 8, 12 and 36 equally spaced beams. All plans were normalized to the same tumor mean dose (< 3%), which is equivalent to the same tumor integral dose. For the pancreas and prostate cases, the patients were assumed to be uniform density. For the nasopharynx case, bones and air cavities were outlined and each assigned a uniform non-unit density. With four or more beams and clinical margin values, the variation in NTID was < 1% as a function of number of beams. With eight or more beams, the variation was < 0.2%. Reducing the beam margin decreased the NTID because less normal tissue was irradiated. However, the effect of the number of beams on NTID was independent of margin size. Higher energy beams reduced the NTID, as expected, and the effect was independent of the number of beams. With four or more beams, variation in beam direction changed NTID by less than 1.5%. Changing beam weights changed NTID by < 2% for plans with four to eight beams. For the body sites studied, the majority of energy was deposited in nontumor tissue, ranging from 72% in the nasopharynx case to 97% for the prostate case. The NTID decreased with increasing tumor size for similar anatomic sizes and increased with increasing size of anatomical region for similar tumor size. Finally, the effect of heterogeneity-corrected doses on the NTID was found to be < 3% for the nasopharynx case. These data support the hypothesis that the NTID is approximately independent of beam orientation or relative weighting when many beams are used. Optimization, therefore, can only find the best distribution of dose; it cannot reduce the energy imparted. NTID may be useful in establishing an upper bound on the quality of plan that can be achieved by optimization.
治疗计划涉及选择能够以将并发症风险降至最低的方式将剂量分布到非肿瘤组织的放疗参数。本研究探讨了非肿瘤组织的积分剂量(NTID)、沉积在非肿瘤组织中的分数能量与三种临床病例(鼻咽癌、胰腺癌和前列腺癌)的各种放疗参数之间的关系。对于密度均匀的器官,积分剂量简单来说就是器官密度、体积和平均剂量的乘积。对于每种病例,分别使用2、4、8、12和36束等间距的射束生成传统计划。所有计划均归一化为相同的肿瘤平均剂量(<3%),这等同于相同的肿瘤积分剂量。对于胰腺癌和前列腺癌病例,假定患者的密度是均匀的。对于鼻咽癌病例,勾勒出骨骼和气腔,并分别赋予其均匀的非单位密度。当使用四束或更多射束以及临床边界值时,NTID随射束数量的变化<1%。当使用八束或更多射束时,变化<0.2%。减小射束边界会降低NTID,因为受照射的正常组织减少了。然而,射束数量对NTID的影响与边界大小无关。正如预期的那样,较高能量的射束会降低NTID,并且这种影响与射束数量无关。当使用四束或更多射束时,射束方向的变化使NTID的改变小于1.5%。对于四至八束射束的计划,改变射束权重使NTID的改变<2%。在所研究的身体部位中,大部分能量沉积在非肿瘤组织中,范围从鼻咽癌病例中的72%到前列腺癌病例中的97%。对于相似的解剖学尺寸,NTID随肿瘤大小的增加而降低;对于相似的肿瘤大小,NTID随解剖学区域大小的增加而增加。最后,发现对于鼻咽癌病例,经不均匀性校正的剂量对NTID的影响<3%。这些数据支持这样的假设:当使用多束射束时,NTID大致与射束方向或相对权重无关。因此,优化只能找到最佳的剂量分布;它无法减少传递的能量。NTID可能有助于确定通过优化能够实现的计划质量的上限。